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 FOREWORD
Knowledge is increasingly recognised as a factor that can boost the competitiveness of regions and coun-
tries. Indeed, knowledge and innovation are the key factors in ensuring that Flanders retains its prosperity
and welfare in the future. Small regions like Flanders need to develop a strategic vision if they are to
make any mark on the international scene. They must resist any fragmentation of their limited
resources. The government, companies and knowledge institutions must join forces to create focus and
critical mass in strategic areas that strengthen Flanders' competitive position and offer potentially sub-
stantial social benefits. It is important, therefore, that we concentrate on those areas in which we can
excel internationally, or at least at European level, and in which we have a comparative advantage. 
The choice of these areas must be guided on the one hand by concrete social and socio-economic needs
and on the other by first-rate research groups that have made it to the top internationally. It is in the
field of tension between the two that foresight studies are conducted. Technology foresight studies can
reveal options for orienting scientific research and technological development while at the same time
creating a decision-supporting framework for regional innovation policy and its relationship with regional
economic developments. 
I see foresight studies as an excellent means of linking science and technology with innovation in industry
and society. After all, innovation is a complex process involving many different players. To create a frame-
work in which new applications can lead to economic growth and social development, three types of
innovation need to be taken into account: 'product and service innovation', 'process innovation' and
'structural innovation' leading to a radical overhaul of existing socio-economic structures. Such 'structural'
or 'socio-economic' innovation is largely the responsibility of government: it is up to the government to
create a favourable climate for enhancing Flanders' innovative strength. As experience in the
Scandinavian countries shows, only where all three types of innovation are present at the same time and
working in harmony can innovation generate economic growth and employment. 
Launched in early 2005, this research project undertaken by the Flemish Science Policy Council (VRWB)
examines the strategic choices that need to be made regarding technology and innovation in order to
secure Flanders' future prosperity and welfare. This project was preceded by a long gestation process. 
As early as 1986, when the VRWB was launched, the then President of the Flemish government Gaston
Geens saw foresight studies underpinned by a long-term vision as a key element in the VRWB's work.
Since then the VRWB, in collaboration with Incentim K.U.Leuven, has built up considerable experience
in organising and managing technology foresight projects. A methodological framework for science and
technology foresight studies has been developed and tested out on two sectors of importance to the
Flemish economy, namely chemicals and food. 
 This foresight study - a collaboration between 130 technical and economic experts from industry and
knowledge institutions - identifies 30 priorities and 15 preconditions within six clusters of strategic 
importance to Flanders. The findings of the study are set out in this report, which also makes a number
of recommendations. The VRWB's principle aim is to provide a reference framework on innovation-relat-
ed activities in Flanders for all stakeholders. If we are to enhance Flanders' innovative strength, 
simultaneous and coordinated attention needs to be paid to both priorities (product and process 
innovation) and  critical preconditions (structural innovation). 
The Foresight Steering Committee, which I chaired, was responsible for overseeing the project while the
VRWB project team prepared and carried out the actual study. Scientific support was provided by
Incentim, K.U.Leuven. The entire prioritisation process is described in the second volume of this series of
studies entitled "Technology and Innovation in Flanders: Priorities – Prioritisation Process and Findings"
(Smits E. et al., 2006). 
I would like to congratulate the VRWB's staff, led by Elisabeth Monard and Danielle Raspoet, for this
wonderful project and for ensuring that the whole process ran smoothly. My sincerest thanks go to
Professor Koenraad Debackere, Incentim K.U.Leuven, the Foresight Steering Committee, the Policy
Research Centre for R&D Statistics, the Policy Research Centre for Entrepreneurship, Enterprises and
Innovation, as well as all the experts who offered their assistance with the project. 
Karel Vinck
President
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EXECUTIVE SUMMARY
In early 2005, the Flemish Science Policy Council (VRWB) launched a research project into strategic
decisions on technology and innovation with a view to ensuring Flanders' future prosperity and welfare.
Insights into the current situation regarding scientific research, technological development, innovation
and economic activity in Flanders, and into key and relevant trends in the fields of research and
innovation, as analysed in international foresight studies, have made it possible to set priorities via 
a broad consultation process. 
Based on how well the technical and economic strengths of Flanders
1 match up with the technical and
economic trends identified in a recent European foresight study
2, the Steering Committee selected the
following six strategic clusters: 
Strategic cluster 1: Transport-Logistics-Services-Supply Chain Management
Strategic cluster 2: ICT and Services in Healthcare
Strategic cluster 3: Healthcare-Food-Prevention and Treatment
Strategic cluster 4: New Materials-Nanotechnology-Manufacturing Industry
Strategic cluster 5: ICT for Socio-economic Innovation
Strategic cluster 6: Energy and Environment for Services and Manufacturing Industry
The prioritisation is the result of an interactive and iterative consultation process involving 130 technical
and economic experts divided into six panels, one for each strategic cluster. Working on the basis of an
international trend analysis, the expert panels started with around 160 technical and economic
developments, from which they selected 30 priorities for Flanders based on a positioning and delphi
analysis (see Table 1 for a summary of the priorities). In addition, 15 preconditions were listed for the
purpose of increasing Flanders' innovative strength. 
The 30 priorities and 15 preconditions within the six strategic clusters were validated by the Foresight
Steering Committee. Then, on 22 June 2006, the Council discussed the findings of the foresight study in
detail and drew up recommendations. The Council considers prioritisation of technology and innovation
to be a reference framework for all stakeholders in Flanders: the government, industry and knowledge
institutions. 
1 Based on data of the Policy Research Centre for R&D Statistics at the Policy Research Centre for Entrepreneurship, Enterprises and
Innovation
2 Key Technologies Cluster Approach, European Commission, 2005 http:// www.cordis.lu/foresight/kte_expert_group_2005.htm10
summary
A more systematic approach to foresight studies will create a policy framework for Flemish policymakers
that can support and motivate strategic policy decisions on technology and innovation. The foresight
study is a lively, dynamic process with a broad support base that dovetails nicely with European
initiatives. With this study, the VRWB has succeeded in getting all of the stakeholders significantly
involved in innovation-related activities, and therefore in the future of Flanders.11
summary
Table 1: Priorities for six strategic clusters in Flanders 
Six strategic clusters  Priorities for Flanders
for Flanders
> Intermodal transport 
> Intelligent supply chain management 
> Intelligent transport systems 
> Virtual design and production  
> E-health with the emphasis on the electronic medical file and
the integration of multiple healthcare information systems  
> Innovative healthcare services and products for 
(home-based) healthcare  
> Medical imaging and processing  
> Multidisciplinarity: bioinformatics, chemoinformatics, 
neuroinformatics  
> Molecular diagnostics and biomarkers
> Preventive and therapeutic vaccines
> Cell therapy
> Molecular biological research for targeted diagnosis and 
therapy
> Translational medicine
> Interdisciplinarity with applications in healthcare
> Relationship between food and health 
> Agricultural biotechnology 
> Industrial biotechnology
> Structured micro- and nanomaterials
> Materials for nanoelectronics, micro-optics, photonics, 
micro-mechanics, etc.
> Unique composites
> Materials and material systems that interact with the 
environment 
> Enabling technologies
> Advanced networks: broadband, mobile, wireless 
> Properties/criteria of advanced networks: 
ambient intelligence, context awareness, security
> Converging technologies and application development 
> E-applications: e-health and e-society
> Efficient use of energy in industry and buildings
> Smart grids
> Power generation 
> Sustainability of production processes and products
Strategic cluster 1:
Transport - Logistics - Services - 
Supply Chain Management  
Strategic cluster 2:
ICT and Services in Healthcare
Strategic cluster 3:
Healthcare: 
Prevention and Treatment 
Food and Agriculture
Strategic cluster 4:
New Materials - Nanotechnology -
Manufacturing Industry 
Strategic cluster 5:
ICT for Socio-economic Innovation 
Strategic cluster 6:
Energy and Environment for Services 







STRATEGIC CLUSTER  1
TRANSPORT-LOGISTICS-SERVICES-
SUPPLY CHAIN MANAGEMENT 
The transport and logistics industry is set to develop significantly under the influence of a broad array of
technologies. The transport systems of the future must meet the rising quantitative needs and changing
qualitative demands of users, in such areas as functionality, quality, safety, reliability, sustainability and
environmental impact. For Flanders, implementing an effective and efficient intermodal transport model,
further expanding intelligent supply chain management techniques and developing and creating
intelligent transport systems are definite priorities for the coming years. 
By making greater use of virtual design and production techniques as it works towards these priorities,




To increase the intermodality and interoperability of transport networks, rational and powerful
management and information systems need to be introduced and innovative terminals created which will
enable the integrated development of air, sea, inland waterway, rail and road transport. Eliminating
bottlenecks that hamper the interconnectivity and interoperability of infrastructure, vehicles, access
modes, payment methods and information, will allow transport time to be reduced. Developing air, sea,
inland waterway, rail and road transport on an integrated, intermodal basis will also make it possible to
boost transport speed and frequency, improve reliability for users and build in more flexibility. 
Intelligent supply chain management (focusing on and integrating the entire chain) 
Organising and optimally managing an intelligent supply chain requires coherent decision-making for all
processes in the supply chain, from production right through to the organisation of the logistical chain.
The ultimate aim should be a truly integrated system of enterprise management involving cooperation
across organisational boundaries (e.g. through networks). Advanced logistical information systems, such
as enterprise resource planning (ERP) solutions (e.g. forecasting, scheduling, supply network planning),
can be used to synchronise goods and data flows and ultimately to automate, integrate and optimise
operating processes. ICT innovations and the constant search for and application of process innovations
are vital for optimising companies' overall supply chain management. 
The intelligence of supply chain management will increase further under the influence of various factors,
including the development and implementation of the following elements and concepts: CRM packages
with data mining, collaborative extended supply chain, voice picking, virtual manufacturing, extensive
automation (robotics), application of lean production or lean manufacturing principles, cost-to-serve,
material requirements planning (MRP), warehouse management systems (WMS), transport management
systems (TMS) and advanced planning & scheduling (APS), mobile resource management, etc. 
Continually enhancing the intelligence of supply chain management is arguably more important for Flanders
than for other regions due to both its high population density and  the major role already played there by the
logistics sector. Indeed, logistics fulfils a highly strategic function for industrial enterprises based in Flanders. 17
transport-logistics-services-
supply chain management
Intelligent transport systems (flexible, adaptable, innovative transport networks) 
New telematics applications derived from soft/hardware and ICT innovations will impact steadily on
vehicle intelligence over the coming decades. Through direct coupling with vehicle intelligence, the
intelligence of transport systems and networks should be enhanced with the introduction of the latest IT
and ICT technologies. The use of Intelligent Transport Systems architecture, the introduction of Global
Systems for Telematics (GST), the expansion of GPS and GIS support and the use of digital information
systems via mobile and wireless (inter)networks should result in a more intelligent and flexible transport
infrastructure and more efficient management of transport flows. Transport speed could eventually start
to increase again as a result. In time, we also expect to see an extensive integration with information and
communication networks, which will also enable corrective action to be taken (Guided Vehicle
Navigation, global positioning, built-in (mobile) ICT systems, use of speech technologies and user-
friendly (multimodal, 3D) interfaces and displays).
Virtual design and production (products, vehicles, (operating) processes and systems) 
Virtual design and production of products makes it possible to analyse and optimise the
manufacturability, assemblability and design of vehicles and products without the need for physical
prototypes. By increasing their use of advanced systems such as simulation, measuring, monitoring and
testing techniques, companies can speed up the product design and development process (cf. "enabling
technologies" from strategic cluster 4 "New Materials – Nanotechnology - Manufacturing Industry").
These computer-based design and simulation techniques can also be used to very good effect in
developing new transport and transportation systems and even in designing or redesigning operating
processes within the entire supply chain. 
Examples of such intelligent design techniques include virtual manufacturing, for testing
manufacturability, and virtual prototyping, for testing product or system properties (e.g. 3D-CAD,
Graphical Data Processing). The use of computer-aided design and computer-aided manufacturing
(CAD/CAM) tools will become standard practice in product design and production. Product lifecycle
management (PLM) solutions will make it possible to integrate all kinds of information and thereby to
limit throughput time, streamline the production process and cut production costs. In addition,18
transport-logistics-services-
supply chain management
increased automation - in this case robotics - will have a major impact on the production process and
production organisation. 
It should be noted that the vehicle construction sector currently plays a major role in the Flemish
economy. To guarantee the long-term survival of the sector in Flanders, a number of high-tech supporting
activities (e.g. virtual manufacturing) must be developed that can be supplied to these companies, in
addition to offering them various kinds of valuable supply chain activities which are already being
sourced from a variety of different suppliers. The very high added value that these services and activities
represent for assembly and manufacturing firms will encourage these companies to continue operating in




Within this strategic cluster, the following focal points for technology and innovation in Flanders were
identified, in addition to the priorities: 
• Flanders currently has plenty of know-how and expertise on logistics and supply chain management
activities. Ensuring that this remains so in the future is critical. A key task for all parties involved
(academics, business and industry, government) is the provision of appropriate training programmes
and initiatives, so that the latest technologies can be used effectively by properly trained individuals
(e.g. drivers, executive staff, IT experts). 
• The logistics and transport sectors are particularly competitive, not only at the European level but
globally as well. It is therefore important that a number of strategic advantages over other countries
and regions be developed and/or safeguarded, if Flanders is to remain a strong logistical player in the
long term. We must also try to react fastest to broader European trends and developments. 
• The competitive strength of the logistics and transport industry is very heavily influenced by the labour
costs of employees in these sectors, many of whom are low-skilled workers. Flanders scores
particularly badly in this area, given the high labour costs of employees in the sector. 
• The only way that Flemish companies and knowledge institutions can make a difference and retain a
competitive edge over other players is by being smarter, developing innovative concepts more
intelligently and being quicker on the uptake than their rivals (leaving aside the use of new
technologies). The government could play an important catalytic role in this respect. 
• At the moment, small SMEs are failing to implement innovative concepts and technologies sufficiently.
This is due partly to a lack of resources but also to a lack of knowledge about and insight into inherent
opportunities. The government could do more to raise awareness among SMEs so that they pick up
more quickly on innovative trends. Failure to do so will jeopardise the long-term survival of these
smaller logistics companies. The relatively limited learning and absorption capacity of SMEs when it
comes to new technological developments must therefore be a key focal point, both for the enterprises
concerned and for the government and knowledge institutions. 21
ict and services in healthcare 
STRATEGIC CLUSTER 2
ICT AND SERVICES IN HEALTHCARE 
Integrating information and communication technology into healthcare can generate improved quality
and more cost-efficient working practices. Recent years have seen a steady progression in 'e-health'
applications, with the emphasis on the switch from written to electronic medical files. Integrated care
trajectories are supported by an integrated and automated information system - vital in ensuring patient-
orientated procedures and more efficient use of resources. 
Population ageing is expected to mean more new services in the care sector, made possible by the
judicious development and use of ICT platforms. Innovations in home-based care will mean that people
can stay in their homes for longer, which in turn may help to curb the rising costs of healthcare. 
The digitisation of medical imaging and processing is already a reality. Computer-aided diagnosis is very
much on the up, making it possible to analyse vast numbers of medical images. Molecular imaging is a
promising technique for the future. 
Multidisciplinarity and the integration of knowledge from different information sources and fields is
important: the right balance must be struck between in-depth research in specialist fields on the one
hand and interdisciplinary research on the other. More specifically, the integration between ICT and
biotechnology, ICT and chemistry and ICT and neurosciences is particularly important. This convergence
of highly specialised science offers major growth potential as well as opportunities to develop new
applications. 
 22
ict and services in healthcare 
E-health with the emphasis on the electronic medical file and the integration of multiple
healthcare information systems 
Information and communication technology (ICT) is rapidly gaining ground within the healthcare system,
particularly for the exchange, management and collection of medical data and information. 'E-health'
applications are a broader definition of the ICT-driven services set to transform healthcare. Within 
e-health, the emphasis lies on the electronic medical file and the integration of multiple healthcare
information systems. 
ELECTRONIC MEDICAL FILE
The switch from written to electronic medical files is central here. The medical file is defined as a
functional and selective collection of relevant administrative, social, psychological and medical data
pertaining to a patient and managed by his or her GP. One of its purposes is to ensure that the patient
receives the best possible curative and preventive healthcare. An electronic medical file offers a range 
of functional possibilities that help to ensure the quality of day-to-day care. Besides acting as an aide-
mémoire, it also enables information to be consulted and checked, facilitates data integration and
continuity, acts as a convenient reference tool and ensures that information is available to doctors and
hospitals at the same time. In this respect, using an electronic medical file opens up more possibilities
for the doctor: managing and monitoring medication, planning preventive activities at both individual
and population level, detection of problems and rapid access to inputted data.  
INTEGRATION OF MULTIPLE HEALTHCARE INFORMATION SYSTEMS 
The integration of ICT into healthcare is crucial both to improve the quality of service provision and to
make working practices more cost-efficient. The potential economic return is huge in what is - due to
population ageing - a growth market. Information exchange between patient and healthcare provider and
between different healthcare providers takes place via the digital highway. Integrated care trajectories -
supported by an integrated and automated information system - make it possible  to work in a patient-
oriented way and make more efficient use of resources. A wealth of medical information (data, text,
images, sound, reports, documents) can be generated, managed and distributed from one integrated
system, both within the healthcare organisation (intranet) and outside it (extranet). This requires a
standardisation of electronic exchange both inside and outside healthcare institutions. 23
ict and services in healthcare 
Achieving top quality and the best possible patient care must be an overall priority. Privacy and security
are key - and potentially decisive - aspects in this respect. To ensure that these new applications gain
rapid acceptance, research is also needed in the area of legal regulations and legislation. 
Innovative healthcare services and products for (home-based) healthcare 
Cases of illness and disease are set to increase substantially due to population ageing. A rise in the
number of chronic ailments such as diabetes, joint disorders, Alzheimer's, Parkinson's, etc. will spell a
further shift from cure to care. This is expected to result in an increase in (new) healthcare services which
will be made possible by the judicious development and use of ICT platforms. Innovations in the field of
home-based care, such as the creation of intelligent environments, security, domotics, adapted housing,
intelligent and socially acceptable robots, personal alarm systems, personalised health advice and other
convenience services, mean that people can stay in their homes for longer, which in turn may help to
curb the rising costs of healthcare. In fact, the challenge for the future will be to provide not just more
care but also better quality care, i.e. care that is effective, safe and accessible to all. The threshold for
innovation in the field of (home-based) healthcare is more one of user acceptance than of technology. 
Medical imaging and processing 
We are seeing a rapid development of multiple medical imaging techniques thanks to the growing
possibilities of ICT. The main feature of the next few years will therefore be the mass transition to digital
imaging and processing. 
COMPUTER-ASSISTED READING, DIAGNOSIS AND THERAPY
The volume of diagnostic images is overwhelming and precious time is lost examining them all in detail.
Techniques include three-dimensional imaging, used to gain a more accurate idea of a required radiation
treatment, and real-time imaging (simultaneous diagnosis and treatment) which is used to assist
minimally invasive surgery. In addition, more and more diagnostic images are being produced as a result
of the introduction of screening programmes for common types of cancer. Computer-assisted reading,
diagnosis and therapy is very much on the increase. 24
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MOLECULAR AND FUNCTIONAL IMAGING
The ground-breaking techniques of modern molecular biochemistry enable the creation of highly specific
contrast media which can be used in very low concentrations to show up previously inaccessible
processes. This used to be the exclusive preserve of radioactive tracers, but now a new generation of
functional binding molecules are emerging that can be used as tracers. Combining these new contrast
media with optimised imaging could prove highly effective in detecting diseases like cancer at a very early
stage by means of specific molecular indicators in the body. Hence, the integration of anatomic and
functional scans will become a reality, as molecular chemistry and imaging converge. Molecular imaging
also holds out the prospect of combining localisation, diagnosis and treatment. Molecular diagnosis and
therapy based on a person's individual genetic and current condition is likely to be possible in the future. 
The big challenge for medical imaging, and brain imaging in particular, will be data validation and the
combination and integration of multiple information sources. Developments are needed based on
increased multidisciplinarity in various fields of the neurosciences, clinical sciences, biosciences and
statistical analysis. 
Multidisciplinarity: informatics applied to biotechnology, chemistry and neurosciences 
(bioinformatics - chemoinformatics - neuroinformatics) 
Multidisciplinarity and the integration of knowledge from different information sources and fields is
important: the right balance needs to be struck between in-depth research in specialist fields on the one
hand and interdisciplinary research on the other. More specifically, the integration between ICT and
biotechnology, ICT and chemistry and ICT and neurosciences is particularly important. This convergence
of highly specialised science offers large growth potential as well as opportunities to develop new
applications. However, the increase in multidisciplinary research will place high demands on new
educational programmes which will need to find the right balance between specialisation and
interdisciplinarity across all relevant disciplines and fields.  25
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LARGE-SCALE DATA COLLECTION AND SYSTEM BIOLOGY 
Where the integration of biological data and processes is concerned, the emphasis is on large-scale data
collection and system biology: 
• large-scale data collection: using high-throughput technologies for generating data to clarify 
the function of genes and gene products and their interactions in complex networks (genomics,
proteomics, etc.). 
• system biology: multidisciplinary research integrating a broad range of biological data and developing
and applying system approaches for understanding and modelling biological processes. 
BIOINFORMATICS
21st century medicine will acquire a whole new dimension through the convergence of ICT and
biotechnology. The gradual blending of the two disciplines will bring some major innovations in its wake.
For example, significant progress is expected to be made in bioinformatics (in combination with
functional genomics), leading to an improved understanding of gene and protein functions over the next
five to ten years. Further developments of biological algorithms will enable new protein functions to be
discovered from DNA and protein databases. Methods for decoding information from DNA patterns will
be available for the whole genome. Fast and cheap DNA sequencing methods are also expected to be
used to analyse the whole genome including single nucleotide polymorphisms (SNPs), with a view to
developing individual therapy concepts. In short, bioinformatics is likely to play a crucial role in the use of
large quantities of data derived from proteomics and functional genomics. Besides computing power,
another important focal point is analysis/modelling (mathematical and statistical knowledge), which is
closely connected with domain knowledge in biotechnology. 
CHEMOINFORMATICS
Rational development of medicines using in silico techniques is a new computer-based drug
development method. By simulating processes and selecting candidate drugs virtually, results can be
achieved more quickly. The affinity of a chemical compound with a biological protein and toxicological
profile can also be in-silico screened. In-silico techniques in chemistry and biotechnology speed up the
process significantly and make a valuable contribution to drug development, for example. 26
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These techniques are applied at the start of the development trajectory: the faster good candidate drugs
(compounds) are selected from the data, the more efficient their subsequent development. This virtual
screening procedure saves time and money during the drug development process. 
NEUROINFORMATICS
Neuroinformatics will play an increasingly major role in the development of the neurosciences. The brain
is an organ of unparalleled complexity, at all levels of its biological organisation, from the molecular to
the behavioural. Functions are coupled to dynamic processes, which all too often exceed scientific
understanding. Given the complexity of their field, neuroscientists have reached a point where methods
based on informatics and the computer sciences have become essential to its further development. 
This is because neuroscientific data are extremely varied and derived from different levels (biological,
chemical, physical, clinical and behavioural) and processes (in space and time, static and dynamic in
nature). 27
ict and services in healthcare 
Focal points
Within this strategic cluster, the following focal points for technology and innovation in Flanders were
identified, in addition to the priorities: 
• Healthcare is a federal issue, so the Flemish government can only make recommendations. 
• Administration accounts for a significant part of the total cost of healthcare and computerisation could
generate a substantial economic return in this area. 
• The expansion of ICT in healthcare is not so much linked to technological and economic limitations as
to institutions' traditional ideas about investment approach and philosophy. The biggest revolution will
be changing the way they work. Obstacles are: a lack of effective privacy, security requirements with
respect to electronic medical communication, no economic incentive (the recommending doctor only
has costs, no returns), too few clinicians are involved in determining the field of application. 
• Restrictive regulations: healthcare has more regulatory requirements than any other sector and these
mean that many things cannot be done. 
• In-depth knowledge of cognitive neurosciences is essential: 
Robots need to be not only intelligent but also acceptable to older people and patients by being
attuned to the individual's cognitive style. Bringing about this technological revolution will require 
in-depth knowledge of how people interact with computers. Developments in the field of cognitive
sciences will play an important role in this respect. Training programmes for IT specialists will
therefore need to pay attention to the interaction/interface between users and the ICT service. 29
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STRATEGIC CLUSTER  3
HEALTHCARE - FOOD 
PREVENTION AND TREATMENT 
Given the ageing society in which we live, technological innovation in healthcare is our number one
challenge for the future. Molecular diagnostics will play an increasingly major role. Based on their
(epi)genetic profile, it will be possible to tell which individuals are predisposed to which diseases and
how those will progress over time. Using biomarkers, which operate at the interface between diagnostics
and therapeutics, the most appropriate therapy for the patient can be selected, thereby marking a step
towards personalised medicine. Major progress in biotechnology combined with increased knowledge of
infectious diseases and immunology will result in the development of new vaccines. Investments in
biotechnology platforms with a view to efficient vaccine production will significantly alter the vaccine
landscape. Biotechnology developments are also increasingly used for therapeutic purposes. Cell therapy
is evolving rapidly. Over the coming decade, the unravelling of the molecular mechanisms responsible for
particular disorders will enable earlier and more accurate diagnosis as well as targeted therapy.
Translational research, i.e. research conducted at the laboratory-clinic interface, has a particularly
important role in improving treatment methods. Modern research in the life sciences is characterised by
its increasing scope and complexity. Here too, interdisciplinarity is the watchword. We expect to see
increased convergence between biotechnology, nanotechnology, information technology and the cognitive
sciences, throwing up an array of potential healthcare applications. A combination of well trained staff
and high-quality facilities is essential if we are to maintain the competitive strength of Flanders' research
infrastructure. 
The relationship between food and health will become increasingly pronounced through interdisciplinary
research involving food and medical sciences. In the agriculture and food sector, more genetic
modification of crops is expected as a result of expanded knowledge in the fields of genetics and
molecular biology. This will enable crops to be developed which are more in line with the needs of
consumers and industry, with resistance to disease, productivity and tolerance of extreme environmental
factors being the priority. Finally, industrial biotechnology is very much on the rise in terms of




HEALTHCARE: PREVENTION AND TREATMENT 
Molecular diagnostics and biomarkers 
Molecular biological techniques in the field of diagnostics are gaining in importance. Molecular diagnostics
focuses on characterisation of the DNA and RNA profile, epigenetic factors (e.g. DNA methylation) and
protein markers (expression level, post-translational modification, etc.) of the patient. It will increasingly be
possible, based on their (epi)genetic profile, to establish which individuals are predisposed to which
illnesses (predictive genetic tests) and how these illnesses will develop. Molecular diagnostics can be used
in many areas including clinical chemistry, pathology, microbiology, clinical genetics, hematology,
immunology, pharmacogenetics and oncology. 
Molecular diagnostics uses a variety of techniques (DNA chip and microarray technology). The method
chosen depends very much on the circumstances and the clinical material to be tested. Molecular
diagnostics can be used, for example, in detecting and predicting hereditary diseases. Such pathologies are
the result either of chromosomal abnormalities, which can be viewed microscopically, or of mutations in the
DNA. Molecular diagnostics can also be used for risk-profiling of multi-factor diseases resulting from a
complex interaction between genetic predisposition and environmental factors. 
Biomarkers operate at the interface between diagnostics and therapeutics. They can be used in the
development of drugs, where they make the process both cheaper and more effective. With biomarkers, it
will also be possible to detect diseases at an earlier stage and to determine whether a patient will respond
well to a particular drug (some drugs not being effective on a small minority of patients). Currently,
developing a new drug costs on average 800 million euro and takes around twelve years. Time-consuming
and expensive clinical studies are needed to test such factors as the safety and efficacy of a potential drug. 
In some cases, studies reveal that the potential drug is not effective, or only effective on a small number of
patients. Currently, there is no way of telling in the development phase whether a candidate drug is effective. 
Biomarkers can bridge this gap, substantially cutting development costs and time. They will also enable the
targeted application of therapies, so that a potential drug is administered to those patients on whom it will
prove effective. In oncology, for example, most drugs only help a limited number of patients. 31
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With biomarkers, the right therapy for individual patients can be selected, marking a step towards
personalised medicine. Biomarkers will also make it possible to detect life-threatening illnesses such as
cancer at an earlier stage. The impact of biomarkers on patients, and indirectly on the social security system,
will be huge. 
Preventive and therapeutic vaccines 
Major progress in biotechnology combined with increased knowledge of infectious diseases and
immunology will play an important role in the development of new vaccines. The search for new vaccines
is geared towards safer and more effective variants without the drawbacks of existing vaccines, as well, of
course, as vaccines against illnesses for which none currently exist. By 2015, 80 new preventive vaccines
will have been marketed worldwide. The next generation of vaccines are likely to be mostly subunit
vaccines, i.e. those based on fragments of a virus or bacterium. Work is also under way on new
administration routes for vaccines (nose sprays and skin patches) and on more combination vaccines. 
Biotechnology techniques can help in the production of weakened bacteria or virus strains. They also
eliminate many of the problems associated with other vaccine production methods: vaccines made from
human blood, for example, may contain viruses or prions, whilst those grown in egg white can trigger
allergic reactions in patients. Investments in biotechnology platforms with a view to efficient vaccine
production will significantly alter the vaccine landscape. Such research is urgently needed for the
development of pandemic influenza vaccines. This technology will also be useful for other vaccine
developments. 
Vaccines against cancer-causing viruses such as the human papilloma virus, which can lead to cervical
cancer, would drastically cut the number of cancer cases. The prototype vaccine against cervical cancer is
due to be marketed in Europe late this year, paving the way for many other anti-cancer vaccines. 
A distinction does however need to be drawn between preventive cancer vaccines and therapeutic cancer
vaccines, for which a number of prototypes are currently being developed (lung, breast and skin cancer). 32
healthcare - food
prevention and treatment
Cell therapy  
Biotechnology techniques are being used more and more for therapeutic purposes. More specific, cell
therapy is rapidly evolving. Living cells are implanted into a patient to produce natural substances which
the patient cannot produce himself. 
- Research on embryonic stem cells: Embryonic stem cells are pluripotent, which means that they can
differentiate into any of several types of cell. Stem cell research needs to take place within international
cooperation programmes that offer the complementary expertise needed for translation into
applications. Examples of possible applications are pancreas cells for treating diabetes mellitus. 
- Tissue engineering: Major progress is expected in the cultivation of differentiated cells using tissue
engineering. Within 10 to 15 years, it will be possible to grow living and dividing cells for a patient on
artificially produced biomaterials, using either autologous (i.e. provided by the patient) or allogeneic
(i.e. provided by a donor) material. Tissue engineering will be an important alternative to
transplantation and artificial implants. To obtain a successful tissue engineering product, a key
challenge for the future will be scaling up from lab scale to a clinically usable product. 
- Xenotransplantation: This is where animals are used as organ donors. The basic thinking is not new:
pigs' heart valves have been used for many years in heart patients. The animals need to be genetically
modified in order to prevent organ rejection. The technique of xenotransplantation is still under
development. 
- Regenerative medicine: This branch of medicine aims to treat diseases characterised  by irreparable
tissue damage.
Molecular biological research for targeted diagnosis and therapy 
Over the next decade, our knowledge of the molecular mechanisms responsible for particular conditions
is set to develop exponentially, e.g. through research into cancer, inflammatory diseases (Crohn's,
multiple sclerosis, etc.) and brain diseases (Alzheimer's, Parkinson's, dementia, depression, etc.). 33
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The unravelling of these molecular mechanisms will result in ever earlier and more accurate diagnosis
and targeted therapy. 
Our expanding knowledge of the human genome will also provide information about the individual
differences in the metabolic transformation of drugs. The biggest variation in the effect of drugs is
caused by the patient's (epi)genetic profile (cf. pharmacogenomics). 
A combination of well trained staff and high-quality facilities is vital to safeguard the future
competitiveness of research infrastructure in Flanders. 
Translational medicine
Scientific research is and will continue to be a constant generator of progress in the treatment of specific
conditions. Research at the laboratory-clinic interface, known as translational research, is particularly
important in ensuring constant improvements in treatment results. Translation research often takes place
while patients are being treated at a clinic. 
This type of research requires close daily cooperation between laboratory researchers and clinicians and
between researchers working in different fields. This allows the findings of fundamental and basic
scientific research to be rapidly incorporated into clinical practice, thereby benefiting patients. 
All multidisciplinary approaches with healthcare applications must be encouraged, given the enormous
potential they represent. Flanders has a high density of clinics and knowledge centres which can be
brought together as part of an interdisciplinary approach. Translational research that allows basic
research to converge with clinical practice has a key role to play here. 
Interdisciplinarity with applications in healthcare 
Modern research in the life sciences is characterised by its increasing scope and complexity.
Interdisciplinarity will be the watchword over the coming decade. We expect to see increasing
convergence between at least four major technological and scientific disciplines, namely nanotechnology,34
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biotechnology, information technology and cognitive sciences, yielding numerous potential applications
in healthcare. Each of these disciplines on its own harbours great potential, but brought together they
represent a powerful source of innovation. This convergence of highly specialised science offers potential
for growth along with opportunities for developing new healthcare applications. It is important in this
respect to encourage these emerging fields on the interface of existing disciplines and to gear them
towards tackling major pathologies. 
However, the increase in multidisciplinary research will place high demands on new educational and
research programmes which will need to find the right balance between specialisation and
interdisciplinarity across all relevant disciplines and fields. Initiatives are therefore required to combine
work in the field of training and research. 
LARGE-SCALE DATA COLLECTION AND SYSTEM BIOLOGY
As regards the integration of biological data and processes, the emphasis is on large-scale data collection
and system biology: 
- large-scale data collection: using high-throughput technologies for generating data to clarify 
the function of genes and gene products and their interactions in complex networks (genomics,
proteomics, etc.); 
- system biology: multidisciplinary research that will integrate a broad range of biological data and
develop and apply system approaches for understanding and modelling biological processes.
BIOMEDICAL ENGINEERING 
Biomedical engineering as a whole has a vital role to play in implementing new treatments. 
The importance of technological development, which typically belongs to the domain of biomedical
engineering and which is essential for the scale-up from lab to clinical scale, should not be
underestimated. To achieve this, substantial research and the development of technologies are required




AGRICULTURE AND FOOD 
Relationship between food and health 
Interdisciplinary research between the food sciences and medical sciences will enhance our
understanding of the relationship between food and health. An understanding of  dietary factors and
habits is key to understanding and combating diet-related diseases and disorders. This includes the
development and use of nutrigenomics and system biology and the study of interactions between
nutrition and physiological functions. Research in this area could lead to the reformulation of processed
foods and the development of new foods and diet foods with a view to improved nutritional value and a
more positive impact on health.
Food has been shown to have an ongoing effect on gene expression, and thereby cell and body
metabolism. Besides confirming existing orthomolecular knowledge, nutrigenomics research also creates
new knowledge. For example, we are gaining more and more insight into the relationship between
individual genetic differences and the metabolic effects of foods. Through our increasing knowledge of
the human genome, it will be possible to achieve 'personalised nutrition' by adapting diet to particular
genetic subgroups and to peoples' individual genetic profile.
In the field of food safety, there has been progress in the development of techniques for detecting
harmful substances, micro-organisms, food pathogens and phytopathogens. The trend is towards
'smaller, faster and easier'. 
Consumers are becoming increasingly aware of the effect of food on their health. Sales of foods whose
composition has been altered, usually to make them healthier, are soaring, with categories including
'functional foods', 'novel foods' and 'nutraceuticals' (foods with potential pharmacological benefits).
Probiotics contain a mono- or mixed-culture of micro-organisms that have a beneficial effect on humans
(mainly by enhancing the intestinal flora). Better understanding is also needed as to how to adapt




Agricultural biotechnology  
Our expanding knowledge of genetics and molecular biology will lead to more and more targeted
interventions in crop development. This should make it possible to select crops with the properties
required to meet the needs of consumers and industry, the priority being resistance to disease,
productivity and tolerance of extreme environmental factors combined with a reduced environmental
impact. This fits in well with the move towards a more sustainable society since plants, including
agricultural crops, have a key role to play in the sustainability of our planet. They process greenhouse
gases, produce oxygen and medicinal substances and represent a sustainable source of biomass. In the
next 10 to 20 years, molecular biologists will gain a fundamental insight into the molecules and
mechanisms that guide these processes. 
Based on this knowledge, a totally new sort of agriculture will emerge in our part of the world, one geared
not so much towards mass food production but rather to small-scale, high-quality production of high
value-added agricultural crops. In other words, agriculture will start to move towards high-tech
production of quality raw materials. Agricultural crops can be used as an alternative production source
for high-quality products such as medically active components and new chemicals and drugs, as well as
for renewable materials, efficient biofuels, raw materials for the pharmaceutical industry, textiles sector,
food industry and so on. 
Industrial biotechnology  
Industrial biotechnology is on the up thanks to recently developed genetic techniques. The use of
genetically modified organisms in production processes offers major potential in terms of efficiency and




Within this strategic cluster, the following focal points for technology and innovation in Flanders were
identified, in addition to the priorities: 
• Healthcare is federal issue, so the Flemish government can only make recommendations. 
• Restrictive legislation and regulations: healthcare has more regulatory requirements than any other
sector and these mean that many things cannot be done. Examples include: (1) very tough regulations
on in vivo experiments for the pharmaceutical and cosmetic industry and (2) very tough regulations for
class IV medical devices. Legislation and regulations need to be amended. 
• Flanders is missing out on opportunities due to negative EU policy on genetically modified organisms. 
• Ethical barriers on genetic profiling. 
• Biotechnology developments are largely driven by small biotech companies without the necessary
resources or long-term prospects. It is difficult for biotech companies to secure a short-term financial
return. 
• Importance of vision and coherent policy on training to retain a strong position in the life sciences. 
• In Belgium, 25,000 people work in the pharmaceutical sector, including 7,000 innovative employees
almost all of whom work for foreign companies; the food sector employs 87,000 people, 80% in SMEs.
SMEs need process innovation rather than product innovation. They are looking for small value-added
innovations which they can then market. 
• Lack of cooperation with Flemish hospitals and knowledge institutions in clinical studies and samples. 
• Many developments in this strategic cluster are taking place at scientific and technological level. It will
be difficult to have products on the market by 2015.38
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• Importance of science and technology communication. This has repercussions in terms of recruiting
students, etc. 
• Bottleneck: inadequate funding for biomedical research. Sufficient investment in research infrastructure
is needed in order to maintain a high competitive level. 
• Healthcare applications derived from other fields have been lacking hitherto (cf. nanotechnology). 39
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STRATEGIC CLUSTER 4
NEW MATERIALS - NANOTECHNOLOGY - 
MANUFACTURING INDUSTRY
A number of specific material fields, in which a considerable amount of knowledge and expertise has
already been built up, will be of particular importance to Flanders in the coming years: structured nano-
and micro-materials, materials for micro/nano electronics and  mechanics, unique composites and
materials that interact with the environment. These material-related innovations will be supplemented by
a number of ancillary, but nonetheless essential, technologies. Such 'enabling' technologies include the
development of specific new research and production techniques, material and product characterisation
as well as the whole field of modelling, simulation and metrology. 
The development of new production technologies and new materials will result in new, advanced and
improved products, applications and production processes. Combining materials and material knowledge
from different fields will play a crucial role in this.
 40
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In materials science, we can divide up materials based on a number of different criteria, including
structural properties (nano/micro-structured, nano-mesoporous, powders, coatings, etc.), functional
properties (electronic, chemical, photonic, functionally active/adaptive, etc.) and composition (metallic,
physical, biological, ceramic, polymeric, etc.). Moreover, there is no absolute division between these
classifications, since more and more materials have combinations of properties from different categories
making them harder to catalogue. The multifunctionality of materials is and will remain very important.
Indeed, the process of exchanging and combining materials and material knowledge between different
fields generates many new ideas. Meanwhile, new (practical) applications for materials are being found
every single day. Research into new and advanced materials is what drives innovation both in high-tech
fields like ICT and micro-electronics and in more traditional sectors such as energy, building and textiles,
the transport and vehicle industry and the graphics and packaging industries. Generic materials research
will generate a host of new (in some cases intelligent) materials, products, research and production
techniques and material treatment processes. New advanced materials with a higher knowledge content,
new functions and better performance will be an ever more important factor in maintaining the
competitiveness of Flemish industry. 
A number of specific material-related fields have been identified and promoted as likely to be particularly
important for Flanders over the coming years and in which a considerable amount of knowledge and
expertise has already been built up. This strategic focusing took into account the social relevance of each
of the priorities. Thus, the fields selected had to enable a relatively rapid conversion from research to
practical application. Indeed, the time axis is of particular importance, and when considering which fields
to set as a priority, we had to select those which (from an application point of view) we believe will be
fully developed within a decade. Meanwhile, links must also be established with the existing industrial
fabric and it must be ascertained whether the framework needed to realise these choices within the
prescribed time limit is actually present within the Flemish business world. The priority material fields
chosen in this foresight exercise are: structured nano- and micro-materials, materials for micro/nano
electronics and  mechanics, unique composites and materials that interact with the environment.
Innovations in material technology need to be supported by various ancillary technologies, namely
characterisation techniques, the development of new production technologies and the design and
implementation of modelling and simulation systems. Indeed, characterisation, design and simulation
are vital for a better understanding of material phenomena, for improved material analysis and reliability41
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and for expanding virtual material design and virtual production. Integrating material technology at nano,
molecular and macro level will also spur on the development of new concepts and production
techniques. 
Structured micro- and nanomaterials 
Increased knowledge and experience with materials at nanoscale level will make it possible to create
materials and systems at micro and macro level with predefined structures, properties and behaviour, in
particular: 
• Micro- and nano-structured materials (= non-homogeneous materials in which a particular structure at
micro/nanoscale is adapted or applied); 
• Nano-mesoporous materials; 
• Nanopowders (e.g. for coatings) with various compositions: oxides, ceramic, metallic, semi-conductive,
etc. 
Materials for nanoelectronics, micro-optics, photonics, micro-mechanics, etc. 
Like materials technology, electronics offers a platform for a host of developments and uses in a wide
range of sectors and applications. For example, in electronics, the optical and mechanical properties of
materials and products are increasingly being exploited, in addition to the electrical properties. 
The electronics sector is developing principally through nano-electronics. Radical miniaturisation enables
the performance, speed and capacity of electronic components to be increased (cf. 'electronic functionality').
Attention is moving slowly but steadily towards convergence with other technologies since the enormous
power of micro/nano-system technology (MST/NST) can be used as a platform for the development of
other applications which, although they do not involve information processing, do fall within the broad
field of electronics (e.g. sensors, (O)LEDs, silicon photonics, solar cells). 
• Micro-optics (including (silicon) photonics (e.g. optic chips that use micro-electronics)); 
• Materials with electromechanical properties (for developing actuators and sensors). 42
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Unique composites: biomaterials, metals, ceramic materials, polymers, etc. 
Over the next few years, the following unique composites will acquire much greater importance, both in
research and practical terms: 
• Bio(logical) materials (= materials derived from biological sources); 
• Metallic materials (metals, alloys, metal compounds (oxides, carbides, etc.)); 
• Ceramic materials; 
• Purpose-designed polymers and fibre-reinforced polymers (composites). 
Materials and material systems that interact with the environment 
This heading includes the following materials and material systems: 
• Controlled release materials 
• Coatings: 
- Functionally active and functionally adaptive layers and coatings
(e.g. intelligent coatings for (bio)medical applications)
- Self-repairing interfaces/coatings
• Nanoscale chemical or physical material systems that have a chemical or physical function or react
specifically to certain chemical or physical stimuli. 
• Labs-on-a-chip (= convergence between electronics and a variety of other technologies with biomedical
applications): a lab-on-a-chip is actually a type of a microchip (and thus actually a material system). 
These microchips interact with the environment by means of a microfluid system and readout method
(usually optic). Most labs-on-a-chip are made of glass or plastic, but they can also contain other materials. 
• Biosensors: a biosensor is a material system usually made up of different materials (biological layer,
anchoring layer, sensing layer, electronic layer). 
Enabling technologies  
The term 'enabling technologies' covers a wide array of technologies that play a vital supporting role in
developments in other fields. They include the development of specific new research and production
techniques, characterisation of materials and products, along with the whole field of modelling,43
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simulation and metrology. The supply and marketing of enabling tools as products in their own right is a
high-tech and specific market niche and a major economic activity. 
Some research and application fields make little or no use of these technologies. Establishing a close
relationship between these supporting technologies and the technologies they support is, however,
crucial for creating added value. Besides developing these tools and making them available, there is still a
long way ahead in terms of getting companies to adopt and apply them. 
Combinatorial research techniques and high-throughput screening methods are a potential source of new
and innovative research and production techniques. They can be a major spur to innovation insofar as
they speed up the research and development process considerably by enabling parallel experimentation
combined with automation and miniaturisation, thereby opening up research fields which were untapped
by traditional research methods on time and cost grounds. 
Material characterisation is vital in view of altering material properties and assigning additional functions
to materials. It requires the development and application of advanced and complex characterisation
methods and measurement standards (cf. advanced characterisation). 
Modelling and simulation techniques can be used to enhance a wide variety of products and to perfect
(production) processes. The virtual approach speeds up the design process drastically whilst slashing
design costs. Meanwhile, the need for the quality of modelling to keep pace with these technological
innovations generates new modelling approaches. In this context, we are seeing an increasingly clear
trend towards multidisciplinary M&S, multi-attribute M&S, multi-scale models and integration, multi-
objective optimisation and stochastic design. 
It should be noted that these enabling technologies are not only important for product and process
innovation but also for research itself. Indeed, characterisation, modelling and simulation are factors that
can accelerate research, as physical prototypes do not need to be built for all material or system variants. 44
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Focal points
Within this strategic cluster, the following focal points for technology and innovation in Flanders were
identified, in addition to the priorities: 
• Application fields and social relevance
When determining application fields for materials innovations, synergies must be found with the
existing industrial fabric wherever possible. Industrial applications for advanced materials are possible
in the chemical and pharmaceutical sector, the food and textile sectors, the building sector, the
graphics industry, the packaging industry, the metal sector, the energy sector, the mechanical products
industry and the vehicle industry. However, social issues and problems relating to the ageing
population, globalisation and the rise of the knowledge economy are also important driving forces and
create a support base for materials research and development. Consequently, innovative solutions are
required that will help to address research challenges in major social areas such as healthcare,
communication, transport and logistics, energy and the environment. 
• Human capital aspect 
Flanders currently has plenty of know-how and expertise in the field of materials science and
technology. Ensuring that this remains so in the future is critical. A key task therefore is to provide
appropriate training programmes and initiatives. Meanwhile, the number of scientists with technical
and scientific training graduating from Flemish universities is in decline. In particular, there is a
growing shortage of well trained materials experts. It is imperative that this trend be reversed.
Initiatives to tackle the problem could include establishing clearer profiles and career options for
materials scientists and materials engineers and including materials science more explicitly in the
relevant curricula (engineering, chemistry, physics, biosciences, etc.) as a core application field for
these disciplines. 
• Importance of multifunctionality and cross-fertilisation between disciplines 
In general, it is possible to identify important links and overlaps between the different clusters and the
materials fields. These interrelationships can generate useful cross-fertilisation. In the medium term,
the convergence of knowledge and skills from different disciplines could result in application-driven45
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scientific and technological synergies. By adopting a multidisciplinary approach incorporating
theoretical and experimental methods, a host of new developments and applications may be realised.
The importance of this cannot be underestimated. For example, nanomaterial developments for
medical and life science applications constitute a kind of enabling technology, a platform on which
applications from strategic cluster 3 ("Healthcare - Food - Prevention and Treatment") can propagate
or develop. 
• Research input/output 
We need to avoid complacency when it comes to the relationship between research input (resources)
and research output. We score highly on materials knowledge and research, but the question is
whether the available resources are being used optimally and whether it would be possible to further
optimise output with existing resources by means of greater coordination, more complementarity and
clear agreements between research groups. Optimisation can be achieved by seeking out complemen-
tarity, stepping up cooperation and avoiding the duplication and overlapping of research lines. 
• Cooperation between business and knowledge institutions 
Research cooperation between the business world in general and research centres could be improved.
Much more could be achieved through more efficient collaborative ties between knowledge centres and
companies. This is possibly more of a problem for SMEs than for large companies, who are indeed
beating a path to the door of knowledge institutions. A lot depends on the specialisation of individual
research centres. Whereas some team up mainly with Belgian companies, others work mostly with
companies from abroad. Thanks to the technology advice centres, SMEs too can allocate specific
research assignments to knowledge centres. These centres do bring together a relatively large group of
SMEs who together develop research project proposals that can be submitted to a knowledge centre.
Alongside this, great efforts are required to boost the absorption capacity within business and industry
and to foster the mobility of researchers between industry and knowledge institutions. 
• Innovation paradox 
The innovation paradox is an unmistakable factor in this discussion. We have a lot of very valuable
knowledge in a large number of fields. However, when it comes to translating and converting this
knowledge into economic capital by developing business activities, Flanders and its research46
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community could be doing much better. Although we are at the top in numerous technological fields,
we often lack the capacity to convert this knowledge and innovation into value-adding economic
activities. A major challenge is therefore to develop activities and services that make us better at
marketing and capitalising on our technological knowledge. We need to identify the root causes of this
shortcoming and work out how we can remedy it. A number of ancillary services can be grouped
together under the heading 'support for generating added-value creation', including market research,
market analysis, etc. These will examine where technological developments may lead from a market
perspective, how markets are likely to evolve, how big they will be, and so on. Based on this
information, we can then decide where our knowledge and technology can have the biggest
contribution. The ultimate aim of these activities is to actively support development in areas that will
actually lead to marketable, value-added products. Support for generating added-value creation is
particularly important for SMEs. 
In addition to this, the capacity of some industries or companies to assimilate existing and new
technological developments is often too limited. In many cases they do not need to develop new
generic technologies, they could make substantial progress simply by incorporating more of the
existing technological knowledge into their activities. Many of these players are SMEs, who in general
remain very conservative when it comes to using existing understanding, knowledge and techniques.
This clearly is an illustration of the existence of the innovation paradox in Flanders. 
• Open borders (international focus) 
Flanders should not be viewed as an independent entity where the entire research and innovation chain
must be present and operating in order to keep business afloat. We must take into account the
international context; after all, companies will take inspiration wherever they can find it, whether in
Flanders or elsewhere. Naturally it is often more profitable and efficient to have a knowledge centre
close at hand. However, not all research fields require the entire value chain to be present in Flanders.
What we should be working towards, therefore, is global rather than local optimisation. Open
innovation works in both directions and knowledge institutions need to offer valuable insights to
companies both at home and abroad. Consequently, it is important that Flemish knowledge institutions
excel internationally as well as in Flanders. 47
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• Chemical industry 
The term 'molecular materials' can be applied to an enormous number of materials, since many
properties are built into the molecular bricks out of which these materials are made. Chemistry has a
key role to play throughout the material creation process. When producing a material, the chemistry of
the material has to be very tightly monitored and controlled. Knowledge of chemistry is therefore vital,
as it is in the design of new materials. Moreover, Flanders' chemical sector is at present, economically
speaking, a very important and very large value-adding industry.
This said, it faces, however, a major challenge, one that should arguably be considered a top priority:
the rising costs and limited global supplies of fossil fuels will force the sector to switch from fossil
fuels (oil, coal, etc.) to alternative raw materials, such as biomass. 49
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STRATEGIC CLUSTER 5
ICT FOR SOCIO-ECONOMIC INNOVATION 
The development of advanced networks where users are connected in all places and at all times ('Always
connected', 'Multi-access') is central to innovating our socio-economic fabric. Vital, in this respect, is the
continued technological development of broadband, mobile and wireless applications. One frequently
cited aspect is the need for universally available ICT facilities and applications ('ambient intelligence') that
are both context-aware (cf. information service that considers user context) and user-friendly. Improved
security (cf. privacy/security) of these information services is also high on the agenda. 
The convergence of technologies and multidisciplinary fields (cf. Bio-Nano-Cogno-Info integration) and
the development of new applications as a result of this convergence constitute a major challenge. 
Sweeping computerisation and a focus on innovation in socio-economic sectors (cf. e-health, e-society)
are important for the further development of our knowledge society. Government can play an important
role here. 
The development of new ICT services depends heavily on a number of critical success factors. In this
respect, the Flemish government can create the right environment or context to enable an array of
innovative ICT services to be developed and exported. 
 50
ict for socio-economic innovation
Advanced networks: Broadband/Mobile/Wireless ('Always connected', 'Multi-access')  
The information society is heavily dependent on its infrastructure, where innovation is connected with
the ability to use and combine information from internal and external sources. Advanced networks are
therefore indispensable for our modern knowledge economy. With the internet becoming a pervasive
presence, society is evolving into an intelligent environment in which consumers can use a huge variety
of information, wirelessly anytime ('Always connected') and anywhere (‘Multi-access’). Further
development towards  greater bandwidth, mobile and wireless applications is considered a priority. 
BROADBAND 
Broadband is a rapid data transmission channel operating at a speed of several megabits per second. 
It can work in various ways (fibreglass, cable, telephone line, wireless, even via the electricity network)
and therefore offers the potential to develop new high-quality services in the field of data distribution,
video/internet telephony (Voice over Internet Protocol, VoIP), webcams and streaming video. 
MOBILE AND WIRELESS APPLICATIONS 
Wireless and mobile services will soon be the rule rather than the exception, enabling people to access
the internet, their e-mail and personal data anywhere, anytime. This development is based on
technologies such as Bluetooth (wireless communication between devices up to 10 metres apart), 
WiFi (for wireless Local Area Networks of up to several hundred metres) and WiMax (for long distances
up to several tens of kilometres), not forgetting of course GPRS and UMTS, the 'high-speed' successor to
GSM for mobile phones and PDA. Companies/institutions are increasingly using wireless handheld
computers to consult client data and record work carried out (entry at source). 51
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Properties/criteria of advanced networks 
USER-FRIENDLINESS AND AMBIENT INTELLIGENCE
One of the R&D priorities being promoted is making ICT services less complicated and more user-
friendly (by introducing general standards, for instance), in particular those that significantly enhance
consumer convenience. Incorporating some degree of intelligence (embedded intelligence) into ICT is 
a key part of this.
Advanced networks must also be 'ambient intelligent', making ICT omnipresent, even in everyday objects
(clothes, etc.). ICT therefore needs to be adapted to the cognitive style of the user, so that the ICT service
and user can interact in as relaxed and natural way as possible (e.g. in natural speech). Bringing about
this technological revolution requires in-depth knowledge of how people interact with computers
(developments in the field of cognitive sciences will be important here). Therefore, IT training will need to
pay due attention to the interaction/interface between user and ICT service.
CONTEXT AWARENESS
Context awareness is a property of IT devices used in various day-to-day situations which allows them to
take into account various user characteristics and preferences. 
Common examples of context are the location and movement of the user.
An example of a context-aware application in the tourism sector is where the information that appears on
the user's device (e.g. a PDA) is personalised and takes into account his or her preferences (if the user
indicates a 'cultural' preference, the device might show the location of the nearest museum, for example).
A simple example of a business application might be a telephone that switches automatically to silent
mode when its user is engaged in an important activity such as a meeting: the application then compares
the electronic diary data with the status of the mobile phone.
SECURITY/PRIVACY
A lot of work is needed to solve the security problems associated with intelligent networks in order to
guarantee privacy, protect data and avoid computer viruses, spam and the like. This development will 
be a critical success factor for a number of areas in particular, including wireless communication,
autonomous sensor networks and medical applications. Moreover, with the arrival of the pervasive
internet the problem of security will become increasingly acute. 52
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Converging technologies and application development 
The process of increased cooperation - or even assimilation - between a large number of disciplines is seen 
as very important and offers a wealth of opportunities. This process is known as technology convergence.
Nanotechnology, information technology, biotechnology and the cognitive sciences are moving closer
together (Nano-Info-Bio-Cogno integration). This convergence of highly specialised science offers huge
growth potential as well as opportunities to develop new applications. 
E-applications: e-health and e-society 
ICT is permeating the social and economic fabric of our society to an ever larger extent. 
In recent years, attention has increasingly turned to various kinds of e-applications such as e-work, 
e-media, e-transport, e-health and e-society. E-health and e-society are considered as priorities.
E-health refers to the integration of ICT into healthcare to enhance the quality of service, make working
practices more cost-efficient and optimise time management for healthcare professionals, with a view
ultimately to better healthcare provision. 
E-health applications have been gaining ground in recent years.
E-society refers to the creation of so-called 'communities' (e.g. web-based learning communities, web-
based classifieds such as Craigslist). The exponential increase in internet users and the emergence of
social software models have spurred on the social development of the internet. The Flemish government
could usefully examine how it can support these new kinds of communities with a view to strengthening
the social fabric.
The Flemish government can play an important role in promoting such e-applications (by means of
innovative contracting, the provision of testing grounds, etc.).53
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Focal points 
The development of new ICT services and applications is heavily dependent on a number of transversal
critical success factors. In this respect, the Flemish government can create the right environment or
context to enable an array of innovative ICT services to be developed and exported. These factors are
outlined below. 
• Living action lab for test users 
The industry is only too aware that the driving forces behind the development of new ICT products and
services are not technological developments but the needs and demands of users. It is users who
determine today's market and who decide whether technologies are user-friendly enough to make them
successful. To understand the needs and demands of users, living action labs can be created where a
technology is tried out by test users who then give their feedback. This allows companies to fine-tune
and market their applications. 
• The Flemish government as first customer 
By being the first customer for new applications, the government can play a key role in launching new
ICT products. This support does not need to be financial: the government could allow a company to
use a hospital or social assistance centre as living action labs for a newly developed e-health
application (similar options exist for e-learning in schools, e-security, etc.). The application can thus
acquire the references it needs to gain further access to the market. 
• Balanced support for the whole innovation chain 
The government could facilitate the development of innovative applications by providing more
balanced support for the whole innovation chain, from the long-term basic research where ideas are
generated right through to the testing stage. Care must be taken not to focus exclusively on one aspect
of the innovation chain. 54
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• Cooperation between companies in an open research and innovation model 
One of the key factors for developing successful applications is that companies work together in an
open (research) model (cf. Scandinavian countries). An open model will find more acceptance among
companies if the government provides common platforms and resources (see also 'government as first
customer'). 
• Informing SMEs about financing sources 
The active involvement of SMEs is vital given the key role they play in fostering innovation. It is
therefore important that SMEs are informed about best practices and market entries and that
appropriate financing sources (e.g. the government) are identified. 
• Encouraging creativity 
It is important to encourage creative ('crazy') ideas among young people as these can lead to ICT
service concepts with a significant market impact. 55
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STRATEGIC CLUSTER 6
ENERGY AND ENVIRONMENT FOR SERVICES 
AND MANUFACTURING INDUSTRY 
Energy and environmental technology play an important role in the development of innovative energy
generation and use, as well as of sustainable production processes and products for services and
manufacturing industry. These technologies are not only important within Europe but represent a prominent
and rapidly growing global market with major export opportunities. Energy and environmental technology can
also help to address big socio-economic challenges such as global climate change, the exhaustion of fossil
fuel sources, environmental sustainability, as well as competitiveness and economic growth. The technologies
identified as priorities for Flanders are mainly geared towards more efficient use of energy in industry and
buildings. Innovation in energy generation (cf. solar energy, biomass, efficient use of fossil fuels, nuclear
energy and fuel cells) should be a focal point here. Another key factor are 'smart grids', where energy is
generated and distributed locally in an integrated and efficient way. Environmentally friendly production
processes (cf. 'closed loop'), industrial and agricultural biotechnology and water, air and soil remediation are
also likely to contribute to the sustainability of production processes and products. 
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Efficient use of energy in Industry and Buildings 
Efficient use of energy is an important strategy for safeguarding (future) energy supply, economic growth
and environmental protection. Energy efficiency can be achieved in both industry and buildings. 
EFFICIENT USE OF ENERGY IN INDUSTRY 
Efficient use of energy can be realised in a wide range of energy-intensive industrial branches, including
chemicals, aluminium, steel, pulp and paper, cement, glass and ceramics, food and textiles. Possibilities
for technological innovation include combined heat and power generation (known as 'cogeneration') and
new electrotechnologies (cf. steel production using microwaves). 
EFFICIENT USE OF ENERGY IN BUILDINGS
The most important R&D requirements when it comes to efficient use of energy in buildings can be
grouped into three categories: 
[1] The building shell (advanced insulation techniques, window technology such as thermal insulation
and built-in solar cells, recycled building materials, etc.). 
[2] Equipment and appliances (performance improvements by means of more efficient heat pumps, new
cooling techniques, magnetic and thermo-electric technologies, energy-efficient lighting, innovative
decentralised energy systems such as micro-cogeneration, etc.). 
[3] Hardware and software development for intelligent systems/smart buildings (see also 'smart grids'). 
Integrated concepts such as the 'passive house' could become the building norm of the future and open
up new prospects for more future-oriented, energy-efficient design and construction. By combining a well
thought-out, compact, sun-facing design with excellent insulation and effective draft-proofing, a passive
house allows almost no heat to escape. This is a unique opportunity for the construction industry to
make a mark with new design and building techniques, innovative, intelligent and highly energy-efficient
products for integrated insulation systems, ventilation systems, glazing, frames, windows, doors,
compact heating systems and so on. These investments in comfort, efficiency and building quality could57
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give the construction sector a shot in the arm, create added value, improve its competitive position and
generate sustainable employment gains. 
Smart grids
Continuity of power supply cannot be guaranteed at a time when all links in the generation-grid-user
chain are evolving rapidly. Black-outs can cause major upheaval and disruption to economic processes.
Smart grids are therefore a prerequisite for ensuring a high degree of penetration of distributed power
generation. One might talk of a 'power web', by analogy with the world wide web: whereas the latter
involves data flows, the 'power web' needs to allow energy to flow in different directions and must
therefore be efficiently connected (importance of power electronics). This requires the development of
hardware, e.g. for operating and measurement purposes, and also of highly reliable software for
controlling the system and its components. 
Energy generation 
SOLAR ENERGY
Solar energy is a renewable energy source that could eventually supply a substantial part of our energy
(see also 'efficient use of energy in industry/buildings'). The sector is growing very rapidly and has great
economic potential, mainly due to national market stimulation programmes in the EU and Japan.
Research, both technological and fundamental, is considered necessary.
BIOMASS
Biomaterials and bio-waste are used to produce solid, liquid and gaseous fuels that can be used in the
transport sector, for power generation and heating applications. Although many biomass technologies are
highly advanced, there is still room for more efficiency and improved cost-efficiency (cf. various biomass
conversion technologies such as fermentation to bio-ethanol, anaerobic digestion, etc.). Biomass could
be an economically attractive alternative for the agricultural industry.58
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EFFICIENT USE OF FOSSIL FUELS 
Most energy today is generated from fossil fuels (coal, oil, gas). Fossil fuels can be used (sometimes
combined with biofuels) for various technologies that generate electricity, heat or a combination of
the two. Fossil fuels are also used as raw materials in a large number of industrial sectors (cf. plastics). 
A key challenge is to find better ways of using these fuels whilst minimising their environmental impact. 
We can expect to see developments in the fields of efficiency improvement and cleaner new technologies. 
NUCLEAR ENERGY
Nuclear energy is an important long-term solution for the problems of CO2, fossil fuel dependency and
energy supply. Technological developments in nuclear energy are taking place in various areas, such as
safety at nuclear power stations and R&D linked to the storage/removal/recycling of radioactive material.
Efforts are also focusing on developing more compact and efficient types of power stations. 
FUEL CELLS: FOCUSING ON FUEL CELL DEVELOPMENT WITHIN KNOWLEDGE INSTITUTIONS 
Innovative fuel cell technology could replace existing technologies (e.g. lithium-ion batteries) in a
multitude of applications (portable appliances such as mobile phones and laptops, cars, decentralised
energy systems such as  fuel cells for micro-cogeneration, etc.) and could be important for decentralised
energy generation (cf. solar energy, wind energy, mini- and micro-cogeneration using sterling engines).
Flemish knowledge institutions must make the development of fuel cells a constant focus of attention. 
Sustainability of production processes and products 
ENVIRONMENTALLY FRIENDLY PRODUCTION PROCESSES ('CLOSED LOOP') 
Production processes and equipment will undergo drastic changes in future under the pressure of
increased cost-efficiency and as environmental consciousness (cf. 'closed loop') and the needs of users
increase. These factors will need to be taken into account at every level and stage of the production
process. 59
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A number of key elements will enable the development of a new production environment: 
- Better understanding of the interactions between materials and processes 
- Improved process knowledge based on mathematics, physics and chemistry 
- Development and application of high-performance production information systems and new
programming platforms. 
Most environmentally friendly production processes can be created within individual production and
consumption sectors such as pulp/paper, plastic, iron/steel, construction, chemicals and textiles.
INDUSTRIAL BIOTECHNOLOGY
Industrial (white) biotechnology promises to yield greater efficiency and a more sustainable production
process (less waste, less energy consumption and the use of biomass as a renewable raw material) than
traditional chemistry and can be used in various sectors: pharmaceuticals (cf. red biotechnology),
chemicals (cf. with industrial-scale biotechnology to produce biodegradable chemicals using living cells
and their enzymes), food production (cf. beer, cheese, wine, etc. using micro-organisms) and so on. 
The use of genetically modified organisms in production processes offers especially great potential. 
AGRICULTURAL BIOTECHNOLOGY 
In the agricultural and food sector, increased knowledge of genetics and molecular biology is expected to
result in more and more genetic interventions on crops, micro-organisms and animals. This will make it
possible to create crops that are more in line with the needs of consumers and industry. Priorities here
are: more efficient use of agricultural land, improved quality, enhanced resistance (making it possible to
cut pesticide use) and improved yields. Another key factor is the need to raise awareness among the
public, who are currently very wary about these developments.
WATER, AIR AND SOIL DECONTAMINATION
A well-functioning economy takes a toll in the form of water, air and soil pollution (e.g. heavy metals in
soil and water, particulate matter and ozone in the air). 
Consequently, there is a strong demand for decontamination technology, both at home and abroad. 
In this priority field, the biggest need is for further technological improvements, with companies taking
the real initiative.61
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PRECONDITIONS 
FOR INCREASING FLANDERS' 
INNOVATIVE STRENGTH
Across all the strategic clusters, the experts also identified and highlighted a number of focal points, not
necessarily relating to a particular field. These more contextual preconditions and critical innovation
factors could potentially have a major impact on Flanders' innovative strength. The following
preconditions were highlighted: 
1) Availability of risk and venture capital 
2) Connection to international networks/partners with a view to effective market operation 
3) Labour market flexibility  
4) Labour costs of researchers
5) Fiscal incentives - taxation 
6) Public procurement: capitalising on the role of the government - as a purchaser of products/services -
in enhancing the effective diffusion of innovation/growth of innovative enterprises
7) Long-term vision (continuity) on research funding
8) Availability of human capital in science/technology fields 
9) Development of new learning methods/curricula enabling faster/more targeted knowledge acquisition
within secondary and higher education and adult education (life long learning). 
10) Science and technology communication targeting users/consumers 
11) Presence of R&D settings geared towards experience (cf. ‘living action lab’ concept enabling
rapid/effective knowledge acquisition geared towards commercial exploitation) 
12) Transfer/feedback of technological innovation to SMEs (for practical application)
13) Flexible approach to dual use (i.e. civil and military applications) 
14) Stable, non-restrictive legislation and regulatory process
15) Less bureaucracy
A questionnaire was then filled in (by 85 respondents across the six strategic clusters) regarding these
preconditions. It asked: 
1) how important they were for increasing Flanders' innovative strength (on a five-point scale ranging
from moderately important to important to essential);
2) what was Flanders' current position with respect to each condition (on a five-point scale ranging from
insufficiently to averagely to highly competitive). 
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The outcome of the survey was unambiguous (see Table 2): all of the preconditions could be considered
as 'important', 'very important' or 'essential' for Flanders' innovative strength. Moreover, Flanders'
current position with respect to the different preconditions was perceived as 'insufficiently' to 'averagely'
competitive. In this way, the experts identified a set of preconditions which were then systematically
classified based on the questionnaire. Naturally, these preconditions can be further refined based on
quantitative economic analyses to gain a more detailed insight into possible policy implications and
resulting policy suggestions. However, this was not one of the aims of the present study. 63
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Table 2: Questionnaire on the preconditions for Flanders' innovative strength: overview of results 
Preconditions Importance for increasing   Flanders' current position
Flanders' innovative strength
Availability of risk capital Essential (5) Insufficiently to averagely 
competitive (2)
Connection to international  Essential (5) Averagely competitive (3)
networks/partners for effective 
market operation
Labour market flexibility   Very important (4) Insufficiently to averagely 
competitive (2)
Labour costs of researchers Very important (4) Insufficiently to averagely 
competitive (2)
Fiscal incentives - Taxation Very important (4) Insufficiently to averagely 
competitive (2)
Public procurement Very important (4) Insufficiently to averagely 
competitive (2)
Long-term vision on research  Essential (5) Insufficiently to averagely 
funding competitive (2)
Availability of human capital in  Essential (5) Averagely competitive (3)
science/technology fields
Development of new learning  Very important (4) Averagely competitive (3)
methods/curricula
Science and technology  Very important (4) Averagely competitive (3)
communication targeting users/
consumers
Presence of R&D settings  Very important (4) Averagely competitive (3)
geared towards experience
Transfer/feedback of technological Very important (4) Insufficiently to averagely 
innovation to SMEs competitive (2)
Flexible approach to dual use Important (3) Averagely competitive (3)
Stable, non-restrictive legislation  Essential (5) Insufficiently to averagely 
and regulations competitive (2)
Less bureaucracy Very important (4) Insufficiently to averagely 
competitive (2)
(The score 1-5 given in brackets indicates a) how important most experts consider the condition to be 
for increasing Flanders' innovative strength and b) the strength of Flanders' current position with respect






Expert-approved prioritisation of technology and innovation in Flanders 
1.The Council fully endorses the prioritisation of the 30 technical and economic developments and 15
critical innovation factors defined by the expert panels within the six strategic clusters. 
2. The prioritisation is the result of an interactive and iterative process involving 130 technical and
economic experts from industry and knowledge institutions divided into six panels, one for each
Strategic Cluster. Working on the basis of an international trend analysis, the expert panels started with
around 160 technical and economic developments, from which they selected 30 priorities for Flanders
based on a strength/weakness analysis. 
3. To increase Flanders' innovative strength, the Council stresses the need to pay simultaneous and
coordinated attention to both priorities (trends) and critical innovation factors (preconditions). 
It emphasises the major responsibility of both the government and social partners in this respect.
Valorisation of the prioritisation by government, industry and knowledge institutions 
4.The Council considers this prioritisation of technology and innovation to be a reference framework 
for all stakeholders in Flanders: the government, industry and knowledge institutions. Valorisation of 
the reference framework operates in two dimensions: intensity, ranging from active influence to
guidance, and policy involvement, ranging from hands-off to hands-on (see Figure 1). 68
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Figure 1: Valorisation of the reference framework 
Government
5.The Council proposes to use this reference framework initially as an assessment framework for existing
instruments and initiatives. In recent years the Flemish government has already created a whole array of
instruments covering the entire innovation chain, for which the reference framework may provide useful
information: 
• New applications within the policy framework for strategic research centres (SRCs) and competence
poles could be assessed against this reference framework.
• The reference framework could be used when drawing up management agreements/ convenants for new
and existing SRCs and competence poles. In fact, the existing SRCs VITO, IMEC, VIB and IBBT, and the
competence poles VIL, Flanders Food, FLAMAC, FMTC, MIP and Flanders Drive, have a clear link with 
the six strategic clusters. 
• The expert-approved prioritisation may also be a vehicle for further implementing the Round Table
concept within a strategic cluster. It will be an innovative and pioneering stimulus with added value for
innovation policy in Flanders. 
• The reference framework could also serve as a guide for the Flemish Innovation Policy Plan, which aims to
integrate innovation-related activities into all policy areas handled by the Flemish government, such as
environment, healthcare, logistics and transport. In this connection, the VRWB refers to its 100th


















6.In the Council's view, the government also has an important role to play as a catalyst in increasing
Flanders' innovative strength. It dealt with this question extensively in its April 2004 memorandum. During
the prioritisation process, the six expert panels identified the following 15 preconditions for increasing
Flanders' innovative strength, known as structural innovation. Figure 2 illustrates the importance for
innovation and Flanders' current position with respect to these 15 preconditions. 
Figure 2: The importance for innovation and Flanders' current position with respect to the 15 preconditions, 
Figure 2: as perceived by the six expert panels. 
Industry
7.This expert-approved prioritisation will also be submitted to the sector federations for further
implementation within their respective sectors, in line with the defined priorities. This will broaden 
the support base still further.  
Knowledge institutions 






























Importance of this foresight study for innovation-related activities in Flanders 
9. A knowledge-intensive society cannot operate without regular, well-founded discussions on the
developments taking place in technical and economic fields. Flanders is no exception, and requires
such discussion exercises at macro-level. A more systematic approach to foresight studies will create
a framework for Flemish policymakers that is capable of supporting and justifying strategic policy
choices on technology and innovation issues. The foresight study is a lively, dynamic process with a
broad support base that dovetails nicely with European initiatives. 
10. With this study, the VRWB has succeeded in getting all of the stakeholders significantly involved in
innovation-related activities, and therefore in the future of Flanders. Expert panels comprising a large
number of highly competent and committed experts from industry and knowledge institutions have
worked together to develop a vision for the future and in so doing have reached a consensus. These
experts have high hopes for the future and are willing to continue to work together on innovation-
related activities in Flanders. 
Danielle Raspoet Karel Vinck
Secretary President
Flemish Science Policy Council Flemish Science Policy Council71
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Foresight Steering Committee (from 1-1-2005 till 31-12-2006)
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MEMBERS:
Prof. Koenraad Debackere, Incentim, K.U.Leuven
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Philippe Vlerick, CEO, BIC-Carpets
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Expert Panel for Strategic Cluster 1
‘Transport - Logistics - Services - Supply Chain Management’
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Prof. Leo Sleuwaegen, Dept. Applied Economics, K.U.Leuven
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Prof. Luc Chalmet, Dept. Management Information Systems, University of Antwerp
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André De Vleeschouwer, Programme Manager, IBBT
Prof. Ben Immers, Dept. Civil Engineering, K.U.Leuven
Prof. Marc Lambrecht, Faculty of Economics and Applied Economics, K.U.Leuven
Prof. Cathy Macharis, MOSI, Vrije Universiteit Brussel
Jozef Maes, Senior Vice-President Marketing & Sales, Asco Industries
Herman Maes, INVOMEC Director, IMEC
Ivo Marechal, Managing Director, Groep H. Essers
Angela Neu-Meij, Logistics-SCM-Purchasing Manager, BASF
Vital Schreurs, CEO, GIM (Geographic Information Management)
Erik Van Celst, Managing Director, Technum
Hendrik Van Dessel, Business Manager, Applied Logistics NV
Prof. Joeri Van Mierlo, ETEC, Vrije Universiteit Brussel
Luc Vandenbroucke, President, Barco View
Jan Vandenhout, Managing Director, ORTEC
Yvan Verbakel, Chief Operating Officer, Bam NV
Prof. Ann Vereecke, Supply Chain Management, Vlerick Leuven Gent Management School
Bart Verhaeghe, President and CEO, Eurinpro Group
Prof. Willy Winkelmans, Dept. Transport and Regional Economics, University of Antwerp  73
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Martin Hinoul, Business Development Manager, K.U.Leuven R&D
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Expert Panel for Strategic Cluster 2
‘ICT and Services in Healthcare’
CHAIRMAN:
Freddy Librecht, former Manager - Techn. Scouting in Healthcare, Agfa-Gevaert
EXPERTS:
Prof. Eric Achten, Dept. Radiology, University Hospital Ghent
Wim De Waele, General Manager, IBBT
Luc Desimpelaere, New Technologies Manager, Barco
Bert Gijselinckx, Human++ Manager, IMEC
Luc Meert, Cross Entity Healthcare, Siemens Medical
Prof. Marc Nyssen, BISI, Vrije Universiteit Brussel
Prof. Guy Orban, Dept. Neurosciences, K.U.Leuven
Prof. Stefaan Peeters, Dept. Physics, University of Antwerp
Koen Schoofs, Product Development Manager, Partezis
Filip Schutyser, CEO, Medicim
Prof. Johan Suykens, ESAT-SISTA, K.U.Leuven
Prof. Bart Van den Bosch, IT Director, University Hospital Leuven
Paul Van Droogenbroeck, Academic Relations Executive, IBM Belgium
Prof. Dirk Van Dyck, Vice-Rector of Research, University of Antwerp
Prof. Bart Van Gheluwe, CEBES Biomechanics Laboratory, Vrije Universiteit Brussel
Ludo Verhoeven, CEO & President, Agfa-Gevaert
Prof. Arthur Vleugels, Director of the Centre for Health Services and Nursing Research, K.U.Leuven
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Elke Smits, Project coordinator, Senior researcher (report)
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Expert Panel for Strategic Cluster 3
‘Healthcare - Food - Prevention and Treatment’
CHAIRMAN:
Staf Van Reet, Manager, Janssen Pharmaceutica NV
EXPERTS:
Prof. Paul Boon, Dept. Neurology, University Hospital Ghent
Jo Bury, Executive Director, VIB (Flanders Institute for Biotechnology)
Prof. Jean-Jacques Cassiman, Dept. Human Genetics, K.U.Leuven
Rita Cortvrindt, CEO, Eggcentris NV
Prof. Geert Crombez, Dept. Experimental Clinical and Health Psychology, Ghent University
Prof. Luc De Vuyst, Dept. Applied Biological Sciences, Vrije Universiteit Brussel
France Fannes, Managing Director, Bio-art NV
Stefan Gijssels, VP Public Affairs, Janssen Pharmaceutica NV
Prof. Dirk Inzé, Dept. Molecular Genetics, Ghent University
Trees Merckx – Van Goey, Vice-President, viWTA – Society & Technology
Prof. Daniel Pipeleers, Director of the Diabetes Research Center, Vrije Universiteit Brussel
Bart Rossel, CEO, Oystershell
Prof. Dirk Snyders, Vice-Chairman of the Research Council, University of Antwerp
Prof. Rony Swennen, Division of Crop Bio-engineering, K.U.Leuven
Prof. Christine Van Broeckhoven, Dept. Molecular Genetics, University of Antwerp
Annie Van Broekhoven, Director of Biologicals, Innogenetics NV
Prof. Wim Van Criekinge, Vice-President, OncoMethylome Sciences
Prof. Pierre Van Damme, Dept. Social Medicine, University of Antwerp
Prof. Hans Van Oosterwyck, Faculty of Engineering, K.U.Leuven
Prof. Jos Vander Sloten, Dept. Mechanical Engineering, K.U.Leuven
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Expert Panel for Strategic Cluster 4
‘New Materials - Nanotechnology -Manufacturing Industry’
CHAIRMAN:
Prof. Gilbert Declerck, President and CEO, IMEC
EXPERTS:
Prof. Roel Baets, Dept. Information Technology, Ghent University
Prof. Yvan Bruynseraede, Dept. Physics and Astronomy, K.U.Leuven
Anton De Proft, CEO, Icos Vision Systems NV
Ilse Garez, Innovation Expert, University College Ghent - TO2C -Centrum
Jan Laperre, R&D Manager, Centexbel
Egbert Lox, Vice-President, Umicore Research, Development and Innovation
Prof. Johan Martens, Centre for Surface Chemistry and Catalysis, K.U.Leuven
Dominique Neerinck, CTO, NV Bekaert SA
Prof. Bart Nicolaï, Division of Mechatronics, Biostatistics and Sensors, K.U.Leuven
Yvan Strauven, R&D Manager, Umicore Research
Serge Tavernier, Industrial Sciences and Technology, Karel de Grote-Hogeschool Antwerp
Christian Van de Sande, Senior Vice-President R&D Materials, Agfa-Gevaert
Herman Van der Auweraer, R&D Manager, LMS International
Prof. Marc Van Parys, Head of Textiles Dept., University College Ghent - TO2C- Centrum
Marc Van Rossum, Advanced Materials & Nano-electronics, IMEC
Prof. Staf Van Tendeloo, Dept. Physics, University of Antwerp
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Prof. Ignace Verpoest, Mechanical Metallurgy Section, K.U.Leuven
Joost Wille, R&D Manager, Sioen Coating NV 
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Expert Panel for Strategic Cluster 5
‘ICT for Socio-economic Innovation’
CHAIRMAN:
John Dejaeger, CEO, BASF Antwerp
EXPERTS:
Frank Bekkers, CEO, I-City
Anthony Belpaire, Product, Marketing & Trust Manager, Certipost
Prof. Chris Blondia, Dept. Mathematics and IT, University of Antwerp
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Prof. Jan Cornelis, Vice-Rector of Research, Vrije Universiteit Brussel
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Wim De Waele, General Manager, IBBT
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Prof. Ignace Lemahieu, Director of Research Affairs, Ghent University
Johan Lenssens, CEO, Opikanoba
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